Real-time enrollment status for this refractory schizophrenia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:52 PM UTC
| NCT Number | NCT03094429 |
| Recruiting Status | Recruiting |
| Condition | Refractory Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 287 participants |
| Active Locations | 1 sites in the US |
| Sponsor | SyneuRx International (Taiwan) Corp |
| Last Updated on CT.gov | September 13, 2021 (Sep 13, 2021) |
As of July 13, 2026: Clinical trial NCT03094429 is currently recruiting participants. This clinical trial study for refractory schizophrenia is actively seeking new participants at 1 location across the United States. The study is sponsored by SyneuRx International (Taiwan) Corp. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03094429 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03094429 was last updated Sep 13, 2021 (September 13, 2021). HelloStudys verifies this status automatically.